Background And Objective: We hypothesized that a biophysical computational model implemented in an object-oriented modeling language (OOML) would provide physiological information and simulative data to study the development and treatment of cardiogenic pulmonary congestion.
Methods: This work is based on the object-oriented cardiopulmonary interaction introduced in [1]. This paper describes the novel model components required to study cardiogenic pulmonary congestion: i) interstitial fluid exchange related to the Starling equation, ii) the lymphatic pump, and iii) the interconnection of these elements with the original cardiopulmonary model. The presented model succeeds in i) describing lymphatic flow at the capillary artery and venous end, ii) activation of the lymphatic pump at elevated pulmonary pressures, and iii) the simulation of the different safety factors related to lung tissue, osmotic gradient, and the lymphatic system during the development of lung congestion.
Results: Simulations show a qualitative correlation between model behavior and physiological data from literature. The model also demonstrates the beneficial effect of continuous positive airway pressure therapy on fluid clearance and respiratory mechanics.
Conclusion: This study demonstrates the successful use of OOML to describe the development of cardiogenic congestion by introducing a model of the lymphatic system and the thoracic fluid balance system, as well as connecting them to the existing cardiopulmonary model.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmpb.2019.104998 | DOI Listing |
Ann Thorac Surg Short Rep
December 2024
Duke University Medical Center, Durham, North Carolina.
Background: Direct mechanical ventricular actuation (DMVA) with the Anstadt cup is effective for non-blood-contacting biventricular support. Pneumatic regulation of a silicone device augments ventricular pump function. Vacuum attachment facilitates diastolic augmentation critical for biventricular support.
View Article and Find Full Text PDFJ Palliat Med
January 2025
Section of Geriatrics and Palliative Care, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Cardiogenic shock (CS) is one of the leading causes of death in patients with myocardial infarction, myocarditis, and congestive heart failure. The utilization patterns of specialist palliative care (PC) consultation in these patients are currently unknown. To determine the utilization of PC in patients with CS and the overall comorbidities of that population.
View Article and Find Full Text PDFJTCVS Open
December 2024
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio.
Objective: To develop a model for preoperatively predicting postcardiotomy cardiogenic shock (PCCS) in patients with poor left ventricular (LV) function undergoing cardiac surgery.
Methods: From the Society of Thoracic Surgeons Adult Cardiac Database, 11,493 patients with LV ejection fraction ≤35% underwent isolated on-pump surgery from 2018 through 2019, of whom 3428 experienced PCCS. In total, 68 preoperative clinical variables were considered in machine-learning algorithms trained and optimized using scikit-learn software.
Front Cardiovasc Med
December 2024
Department of Vascular Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Background: Percutaneous mechanical thrombectomy (PMT) is increasingly used in the treatment of intermediate and high-risk acute pulmonary embolism (PE), and the treatment of high-risk PE with the aid of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has also been reported. However, there are few reports of VA-ECOM-assisted PMT in the treatment of high-risk PE. The purpose of this study is to summarize the data of 11 patients with high-risk PE treated with VA-ECMO assisted PMT, and propose feasible treatment methods for such patients.
View Article and Find Full Text PDFCurr Cardiol Rep
January 2025
Robert M. Berne Cardiovascular Research Center, and Department of Medicine, DivisionofCardiovascularMedicine,HeartandVascularCenter, University of Virginia, Charlottesville, VA, USA.
Purposeof The Review: In this review article, we aim to provide an overview of the pathophysiology, the clinical features, the therapeutic management and prognosis of patients affected by Multisystemic inflammatory syndrome (MIS) with cardiac involvement, focusing on myocarditis and pericarditis.
Recent Findings: MIS is a multiorgan hyperinflammatory condition due to a cytokine storm following (within 4-12 weeks) SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection. First described in children, it also affects young adults without comorbidities, predominantly males with highly heterogeneous clinical manifestations, including cardiac involvement.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!